Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|March 1, 2014
α-Methyldopa-induced hepatitis during the postpartum periodSoleiman Kashkooli, Brandon Baraty, Jamshid Kalantar
Expert Opinion on Drug Safety|April 27, 2019
Safety of drugs used for the treatment of Crohn's diseaseAviv Pudipeddi, Viraj Kariyawasam, Craig Haifer, et al.
Therapeutic Advances in Gastroenterology|March 26, 2026
Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologistsLynna Chen, Leonie Ruddick-Collins, Yoon-Kyo An, et al.
Obstetrics and Gynecology|July 3, 2007
Instituting surveillance guidelines and adverse outcomes in preeclampsiaJennifer Menzies, Laura A Magee, Jing Li, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2020
Systematic review: medical therapy for fibrostenosing Crohn's diseaseCathy Lu, Brandon Baraty, Helen Lee Robertson, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2018
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel diseaseWebber Chan, Nicole Lynch, Peter Bampton, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal LoadingRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Pageof 1